RALGAPA2-C20ORF194 Fusion FISH Probe
The RALGAPA2-C20ORF194 Fusion FISH Probe is used to confirm a fusion of the RALGAPA2 and C20ORF194 genes. The fusion of the RALGAPA2 and C20ORF194 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| RALGAPA2-C20ORF194-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-RERE | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-REOR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-REGO | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-REGR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-OROR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GORE | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GROR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| RALGAPA2-C20ORF194-20-AQAQ | 20 (40 μL) | 200 μL |
|
C20orf194 Gene Summary
This gene encodes an uncharacterized protein with a C-terminal coiled-coil region. The gene is located on chromosome 20p13 in a 1.8 Mb region linked to a spinocerebellar ataxia phenotype, but this gene does not appear to be a disease candidate. [provided by RefSeq, Dec 2011]
Gene Name: Chromosome 20 Open Reading Frame 194
Chromosome: CHR20: 3229947 -3388255
Locus: 20p13
RALGAPA2 Gene Summary
The Ral GTPase Activating Protein Catalytic Alpha Subunit 2 (RALGAPA2) gene is located on chr20 :20370271-20693266 at 20p11.23.
Gene Name: Ral GTPase Activating Protein Catalytic Alpha Subunit 2
Chromosome: CHR20: 20370271 -20693266
Locus: 20p11.23
Gene Diseases
The RALGAPA2 C20ORF194 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|